All Brands

Vitruvias Therapeutics, Inc Issues Nationwide

1 recall on record · Last recall: Aug 24, 2026

Safety Score

97/100

Excellent

Based on recall frequency and severity over the past 3 years, with older recalls weighted less.

Severity Breakdown

Class I — Serious
0
Class II — Moderate
0
Class III — Low Risk
0
Unclassified
1

Categories

MEDICATION

Recall Timeline

FDAAug 21, 2026

Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency

AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.

Track Vitruvias Therapeutics, Inc Issues Nationwide recalls automatically

Get instant alerts when Vitruvias Therapeutics, Inc Issues Nationwide issues a new recall.

Start Free Trial